Hypera S.A. (HYPMY)
OTCMKTS · Delayed Price · Currency is USD
2.920
-0.070 (-2.34%)
Dec 24, 2024, 4:00 PM EST

Hypera Company Description

Hypera S.A. operates as a pharmaceutical company in Brazil.

It offers prescription products under the Adacne, Addera, apri, AmpliumG, pleased, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, Luna, moon, Lydian, macrodantin, MaxSulid, Milgamma, Mioflex – A, Nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, Softalm, Tacroz, Tinodin, Umma, and velunid brands.

The company also provides sun protection and moisturizing skin care products under the Mantecorp Skincare brands; similar products under the Doralgina, Dropy D, Equilibrisse, balance, Flavonid, Histamin, neofresh, neolefrin, neoquimica Vitamins, Neosorum, and Torsilax brands; and over-the-counter drugs under the Apracur, Benegrip, Buscopan, Coristina D Pro, Engov, Epocler, Estomazil, and Neosaldina brands, as well as similar and generic drugs under the Neo Química brand.

In addition, it offers nutritional and vitamin supplement products under the Tamarine, Biotônico Fontoura, and Zero-Cal brands; and generic medicines under the Hydroxyzine, Sodium Diclofenac, Dipyron, Ibuprofen, Losartan Potassium, Mal Dexchlorpheniramine, Naproxene, Paracetamol, Simethicon, Loratadine, Omeprazole, Tadalaphyl, and Desogestrel brands.

The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018.

Hypera S.A. was founded in 1999 and is headquartered in São Paulo, Brazil.

Hypera S.A.
Hypera logo
Country Brazil
Founded 1999
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 10,301
CEO Breno Pires de Oliveira

Contact Details

Address:
Av. Magalhães de Castro, 4800
São Paulo, 05676-120
Brazil
Website hypera.com.br

Stock Details

Ticker Symbol HYPMY
Exchange OTCMKTS
Fiscal Year January - December
Reporting Currency BRL
ISIN Number US44914U1060
SIC Code 2834

Key Executives

Name Position
Breno Pires de Oliveira Chief Executive Officer
Adalmario Satheler do Couto Chief Financial Officer
Carlos Scorsi Chief Operating Officer
Adalmario Satheler do Couto Head of Investor Relations